Research
Research Field
"My work has been steadily focused on the development and application of CRISPR-related tools in a wide range of research areas. The Bae group aims to1) develop novel genome editing tools,
2) apply CRISPR-based methods for the treatment of genetic diseases in vivo and ex vivo,
3) envision the center as a hub for genome editing technologies in different fields, including basic and applied research in plants and animals and in medical science."
Keyword
Genome editing, CRISPR, Gene therapyPublication
- "Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa" Molecular Therapy 30(8), 2664-2679 (2022). (Featured on the front cover)
- "Comprehensive analysis of prime editing outcomes in human embryonic stem cells"" Nucleic Acids Research 50(2), 1187-1197 (2022).
- "In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment" Molecular Therapy 30(1), 119-129 (2022).
- "Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis" Nucleic Acids Research 49, 11312-11322 (2021).
- "High-purity production and precise editing of DNA base editing ribonucleoproteins" Science Advances 7(35), eabg2661 (2021).
- "Adenine base editors engineering reduces editing of bystander cytosines" Nature Biotechnology 39(11), 1426-1433 (2021).
- "Adenine base editing and prime editing of chemically derived hepatic progenitors rescue genetic liver disease" Cell Stem Cell 28(9), 1614-1624 (2021). (Featured on the front cover)
- "PE-Designer and PE-Analyzer: Web-based design and analysis tools for CRISPR prime editing" Nucleic Acids Research 49(W1), W499–W504 (2021).
- "Adenine base editors catalyze cytosine conversions in human cells" Nature Biotechnology 37(10), 1145–1148 (2019).
- "Direct observation of DNA target searching and cleavage by CRISPR-Cas12a" Nature Communications 9, 2777 (2018).